Real World Study in Greek Patients with BPH for Disease Control and QoL Under FDC Treatment with Solifenacin/Tamsulosin.

Clinical trial NCT06528613 · RECRUITING

Trial details

NCT number: NCT06528613
Sponsor: Elpen Pharmaceutical Co. Inc.
Status: RECRUITING
Study type: OBSERVATIONAL

Benign Prostatic Hyperplasia

Start date: 2024-10-23
Primary completion: 2025-09-30
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.